Oruka Therapeutics, Inc. ORKA Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Oruka Therapeutics, Inc. (ORKA) reported operating lease right-of-use assets in other assets of $1.69M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Oruka Therapeutics, Inc.'s operating lease right-of-use assets in other assets increased by 107.2% year-over-year, from $814K to $1.69M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a 33.7% compound annual growth rate (CAGR), from $428K to $1.83M.